December 8, 2021 Non Regulatory Promore Pharma beviljas patent i USA avseende behandling av kroniska sår
December 8, 2021 Non Regulatory Promore Pharma granted US patent regarding treatment of chronic wounds
November 19, 2021 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2021
November 19, 2021 Non Regulatory Inbjudan till telefonkonferens med anledning av Promore Pharmas rapport för det tredje kvartalet 2021
November 16, 2021 Regulatory Nomination Committee Appointed for the Annual General Meeting 2022 in Promore Pharma
November 9, 2021 Regulatory Promore Pharma erhåller tillstånd för att starta fas II klinisk prövning avseende ärrprevension
November 9, 2021 Regulatory Promore Pharma receives permits to start a phase II clinical trial regarding scar prevention
October 25, 2021 Regulatory Promore Pharma meddelar att vetenskaplig artikel publicerats om kliniska studieresultat med ropocamptide för venösa bensår
October 25, 2021 Regulatory Promore Pharma announces that scientific article has been published on clinical study results with ropocamptide for venous leg ulcers
September 13, 2021 Regulatory Promore Pharma receives delivery of hyaluronic acid from Italian manufacturer Fidia
August 17, 2021 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för Q2 2021
August 17, 2021 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Q2 Report 2021
July 20, 2021 Regulatory The rights issue is registered and the trading in Paid Subscription Shares ceases
May 27, 2021 Regulatory Promore Pharma informerar om sista dag för handel för att erhålla teckningsrätter
May 27, 2021 Regulatory Promore Pharma informs about the last day of trading to receive subscription rights
May 27, 2021 Regulatory Report from an extra General Meeting of Promore Pharma AB held on 27 May 2021
May 27, 2021 Regulatory Report from the Annual General Meeting of Promore Pharma AB held on 27 May 2021
May 26, 2021 Non Regulatory Promore Pharma participates in “Småbolagsdagarna 2021”, an event organized by Aktiespararna
May 7, 2021 Regulatory Promore Pharma AB intends to carry out a fully secured rights issue in order to implement the new strategy
May 7, 2021 Regulatory Promore Pharma genomför en fullt garanterad företrädesemission i syfte att genomföra den nya strategin
April 28, 2021 Regulatory Promore Pharma tecknar avtal om produktion av hyaluronsyra med italienska tillverkaren Fidia
April 28, 2021 Regulatory Promore Pharma signs agreement on production of hyaluronic acid with Italian manufacturer Fidia
February 16, 2021 Non Regulatory Inbjudan till presentation av Promore Pharmas bokslutskommuniké för 2020
February 16, 2021 Non Regulatory Invitation to Presentation of Promore Pharma’s Year-end report for 2020